Credit Suisse’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-517,646
| Closed | -$44M | – | 4555 |
|
|
2020
Q3 | $44M | Buy |
517,646
+267,313
| +107% | +$13.5M | 0.03% | 661 |
|
|
2020
Q2 | $8.87M | Buy |
250,333
+129,559
| +107% | +$3.79M | 0.01% | 1360 |
|
|
2020
Q1 | $1.63M | Sell |
120,774
-43,396
| -26% | -$730K | ﹤0.01% | 2274 |
|
|
2019
Q4 | $3.47M | Buy |
164,170
+42,728
| +35% | +$754K | ﹤0.01% | 2162 |
|
|
2019
Q3 | $1.61M | Buy |
121,442
+14,642
| +14% | +$215K | ﹤0.01% | 2639 |
|
|
2019
Q2 | $1.48M | Buy |
106,800
+15,393
| +17% | +$232K | ﹤0.01% | 2661 |
|
|
2019
Q1 | $1.76M | Sell |
91,407
-18,182
| -17% | -$293K | ﹤0.01% | 2467 |
|
|
2018
Q4 | $1.56M | Sell |
109,589
-8,393
| -7% | -$167K | ﹤0.01% | 2425 |
|
|
2018
Q3 | $2.46M | Buy |
117,982
+12,433
| +12% | +$294K | ﹤0.01% | 2212 |
|
|
2018
Q2 | $2.5M | Sell |
105,549
-14,129
| -12% | -$284K | ﹤0.01% | 2270 |
|
|
2018
Q1 | $1.75M | Buy |
119,678
+30,167
| +34% | +$493K | ﹤0.01% | 2537 |
|
|
2017
Q4 | $1.45M | Sell |
89,511
-39,802
| -31% | -$470K | ﹤0.01% | 2718 |
|
|
2017
Q3 | $1.81M | Sell |
129,313
-12,332
| -9% | -$123K | ﹤0.01% | 2630 |
|
|
2017
Q2 | $1.25M | Sell |
141,645
-35,053
| -20% | -$246K | ﹤0.01% | 2555 |
|
|
2017
Q1 | $1.14M | Buy |
176,698
+83,298
| +89% | +$422K | ﹤0.01% | 2769 |
|
|
2016
Q4 | $343K | Sell |
93,400
-547
| -0.6% | -$1.62K | ﹤0.01% | 3601 |
|
|
2016
Q3 | $306K | Sell |
93,947
-33,452
| -26% | -$93.5K | ﹤0.01% | 3650 |
|
|
2016
Q2 | $296K | Buy |
127,399
+30,744
| +32% | +$103K | ﹤0.01% | 3700 |
|
|
2016
Q1 | $241K | Buy |
96,655
+12,190
| +14% | +$27.4K | ﹤0.01% | 3612 |
|
|
2015
Q4 | $259K | Buy |
84,465
+20,961
| +33% | +$58.5K | ﹤0.01% | 3762 |
|
|
2015
Q3 | $109K | Sell |
63,504
-81,590
| -56% | -$208K | ﹤0.01% | 4089 |
|
|
2015
Q2 | $589K | Buy |
145,094
+27,493
| +23% | +$112K | ﹤0.01% | 3599 |
|
|
2015
Q1 | $450K | Buy |
117,601
+2,236
| +2% | +$9.72K | ﹤0.01% | 3614 |
|
|
2014
Q4 | $555K | Buy |
115,365
+75,800
| +192% | +$300K | ﹤0.01% | 3631 |
|
|
2014
Q3 | $147K | Sell |
39,565
-42,248
| -52% | -$143K | ﹤0.01% | 4234 |
|
|
2014
Q2 | $300K | Sell |
81,813
-32,334
| -28% | -$119K | ﹤0.01% | 4110 |
|
|
2014
Q1 | $480K | Buy |
114,147
+20,503
| +22% | +$102K | ﹤0.01% | 3745 |
|
|
2013
Q4 | $431K | Sell |
93,644
-84,105
| -47% | -$375K | ﹤0.01% | 3857 |
|
|
2013
Q3 | $1.1M | Buy |
177,749
+134,554
| +312% | +$775K | ﹤0.01% | 2877 |
|
|
2013
Q2 | $235K | Buy |
+43,195
| New | +$142K | ﹤0.01% | 3785 |
|
Credit Suisse's IMMU Position: Q4 2020 in Review
Credit Suisse sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 517,646 shares — an estimated $44M sold.
Credit Suisse first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $44M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Credit Suisse reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Credit Suisse sold 517,646 Immunomedics Inc shares in Q4 2020, an estimated $44M.
- Credit Suisse first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Credit Suisse's Immunomedics Inc position peaked at $44M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.